Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Childhood acute leukemia, early common infections, and allergy: The ESCALE Study.
Rudant J, Orsi L, Menegaux F, Petit A, Baruchel A, Bertrand Y, Lambilliotte A, Robert A, Michel G, Margueritte G, Tandonnet J, Mechinaud F, Bordigoni P, Hémon D, Clavel J. Rudant J, et al. Among authors: michel g. Am J Epidemiol. 2010 Nov 1;172(9):1015-27. doi: 10.1093/aje/kwq233. Epub 2010 Aug 31. Am J Epidemiol. 2010. PMID: 20807738
Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
Michel G, Gluckman E, Esperou-Bourdeau H, Reiffers J, Pico JL, Bordigoni P, Thuret I, Blaise D, Bernaudin F, Jouet JP, et al. Michel G, et al. J Clin Oncol. 1994 Jun;12(6):1217-22. doi: 10.1200/JCO.1994.12.6.1217. J Clin Oncol. 1994. PMID: 8201385
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.
Cavazzana-Calvo M, Bordigoni P, Michel G, Esperou H, Souillet G, Leblanc T, Stephan JL, Vannier JP, Mechinaud F, Reiffers J, Vilmer E, Landman-Parker J, Benkerrou M, Baruchel A, Pico J, Bernaudin F, Bergeron C, Plouvier E, Thomas C, Wijdenes J, Lacour B, Blanche S, Fischer A. Cavazzana-Calvo M, et al. Among authors: michel g. Br J Haematol. 1996 Apr;93(1):131-8. doi: 10.1046/j.1365-2141.1996.4831024.x. Br J Haematol. 1996. PMID: 8611446 Clinical Trial.
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G. Michel G, et al. Bone Marrow Transplant. 1996 Feb;17(2):191-6. Bone Marrow Transplant. 1996. PMID: 8640165 Clinical Trial.
Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G, Baruchel A, Tabone MD, Nelken B, Leblanc T, Thuret I, Bordigoni P, Bergeron C, Esperou-Bourdeau H, Perel Y, Vannier JP, De Lumley L, Dommergues JP, Lamagnère JP, Couillaud G, Auvrignon A, Schaison G, Leverger G. Michel G, et al. Hematol Cell Ther. 1996 Apr;38(2):169-76. doi: 10.1007/s00282-996-0169-7. Hematol Cell Ther. 1996. PMID: 8931998 Clinical Trial.
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.
Thyss A, Suciu S, Bertrand Y, Mazingue F, Robert A, Vilmer E, Mechinaud F, Benoit Y, Brock P, Ferster A, Lutz P, Boutard P, Marguerite G, Plouvier E, Michel G, Plantaz D, Munzer M, Rialland X, Chantraine JM, Norton L, Solbu G, Philippe N, Otten J. Thyss A, et al. Among authors: michel g. J Clin Oncol. 1997 May;15(5):1824-30. doi: 10.1200/JCO.1997.15.5.1824. J Clin Oncol. 1997. PMID: 9164191
In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.
Cavazzana-Calvo M, Jabado N, Bordigoni P, Michel G, Haddad E, Mechinaud F, Landman-Parker J, Leblanc T, Plouvier E, Baruchel A, Stephan JL, Souillet G, Vilmer E, Wijdenes J, Le Deist F, Fischer A. Cavazzana-Calvo M, et al. Among authors: michel g. Leuk Lymphoma. 1997 Dec;28(1-2):103-12. doi: 10.3109/10428199709058336. Leuk Lymphoma. 1997. PMID: 9498709
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group.
Donadieu J, Auclerc MF, Baruchel A, Leblanc T, Landman-Parker J, Perel Y, Michel G, Cornu G, Bordigoni P, Sommelet D, Leverger G, Hill C, Schaison G. Donadieu J, et al. Among authors: michel g. Br J Haematol. 1998 Aug;102(3):729-39. doi: 10.1046/j.1365-2141.1998.00818.x. Br J Haematol. 1998. PMID: 9722300 Free article.
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Michel G, Landman-Parker J, Auclerc MF, Mathey C, Leblanc T, Legall E, Bordigoni P, Lamagnere JP, Demeocq F, Perel Y, Auvrignon A, Berthou C, Bauduer F, Pautard B, Schneider P, Schaison G, Leverger G, Baruchel A. Michel G, et al. J Clin Oncol. 2000 Apr;18(7):1517-24. doi: 10.1200/JCO.2000.18.7.1517. J Clin Oncol. 2000. PMID: 10735900 Clinical Trial.
1,535 results